RNA-binding proteins, multifaceted translational regulators in cancer

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 7, 2015, Pages 881-886

  Wurth, Laurence ^a,b   Gebauer, Fátima ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Cancer; Cytoplasmic polyadenylation; IRES; RNA binding protein; Translation

Indexed keywords

CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; HUR PROTEIN; LA ANTIGEN; RNA BINDING PROTEIN; TUMOR PROTEIN;

CANCER GROWTH; CARCINOGENESIS; GENE EXPRESSION REGULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; REVIEW; TRANSLATION REGULATION; ANIMAL; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; RNA TRANSLATION;

ANIMALS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; RNA-BINDING PROTEINS;

EID: 84930959238     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.10.001     Document Type: Review

References (97)

1. Mitchell S.F., Parker R. Principles and properties of eukaryotic mRNPs. Mol. Cell 2014, 54:547-558.
2. Baltz A.G., Munschauer M., Schwanhausser B., Vasile A., Murakawa Y., Schueler M., Youngs N., Penfold-Brown D., Drew K., Milek M., et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol. Cell 2012, 46:674-690.
3. Castello A., Fischer B., Eichelbaum K., Horos R., Beckmann B.M., Strein C., Davey N.E., Humphreys D.T., Preiss T., Steinmetz L.M., et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012, 149:1393-1406.
4. Kwon S.C., Yi H., Eichelbaum K., Fohr S., Fischer B., You K.T., Castello A., Krijgsveld J., Hentze M.W., Kim V.N. The RNA-binding protein repertoire of embryonic stem cells. Nat. Struct. Mol. Biol. 2013, 20:1122-1130.
5. Mitchell S.F., Jain S., She M., Parker R. Global analysis of yeast mRNPs. Nat. Struct. Mol. Biol. 2013, 20:127-133.
6. Hennig J., Militti C., Popowicz G.M., Wang I., Sonntag M., Geerlof A., Gabel F., Gebauer F., Sattler M. Structural basis for the assembly of the SXL-UNR translation regulatory complex. Nature 2014, 10.1038/nature13693.
7. Morris A.R., Mukherjee N., Keene J.D. Systematic analysis of posttranscriptional gene expression. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:162-180.
8. Hentze M.W., Preiss T. The REM phase of gene regulation. Trends Biochem. Sci. 2010, 35:423-426.
9. Gray N.K., Quick S., Goossen B., Constable A., Hirling H., Kühn L.C., Hentze M.W. Recombinant iron-regulatory factor functions as an iron-responsive-element-binding protein, a translational repressor and an aconitase. A functional assay for translational repression and direct demonstration of the iron switch. Eur. J. Biochem. 1993, 218:657-667.
10. Volz K. The functional duality of iron regulatory protein 1. Curr. Opin. Struct. Biol. 2008, 18:106-111.
11. Cunningham J.T., Moreno M.V., Lodi A., Ronen S.M., Ruggero D. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell 2014, 157:1088-1103.
12. Castello A., Fischer B., Hentze M.W., Preiss T. RNA-binding proteins in Mendelian disease. Trends Genet. 2013, 29:318-327.
13. Cooper T.A., Wan L., Dreyfuss G. RNA and disease. Cell 2009, 136:777-793.
14. Darnell R.B. RNA regulation in neurologic disease and cancer. Cancer Res. Treat 2010, 42:125-129.
15. Lukong K.E., Chang K.W., Khandjian E.W., Richard S. RNA-binding proteins in human genetic disease. Trends Genet. 2008, 24:416-425.
16. Kechavarzi B., Janga S.C. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014, 15:R14.
17. Di Giammartino D.C., Nishida K., Manley J.L. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 2011, 43:853-866.
18. Mihailovic M., Wurth L., Zambelli F., Abaza I., Militti C., Mancuso F.M., Roma G., Pavesi G., Gebauer F. Widespread generation of alternative UTRs contributes to sex-specific RNA binding by UNR. RNA 2012, 18:53-64.
19. Bava F.A., Eliscovich C., Ferreira P.G., Minana B., Ben-Dov C., Guigo R., Valcarcel J., Mendez R. CPEB1 coordinates alternative 3'-UTR formation with translational regulation. Nature 2013, 495:121-125.
20. Masamha C.P., Xia Z., Yang J., Albrecht T.R., Li M., Shyu A.B., Li W., Wagner E.J. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 2014, 510:412-416.
21. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
22. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
23. Spies N., Burge C.B., Bartel D.P. 3'UTR-isoform choice has limited influence on the stability and translational efficiency of most mRNAs in mouse fibroblasts Genome Res 2013, 12:2078-2090.
24. Bilanges B., Stokoe D. Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007, 26:5973-5990.
25. Ruggero D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 2013, 5. (pii: a012336.).
26. Silvera D., Formenti S.C., Schneider R.J. Translational control in cancer. Nat. Rev. Cancer 2010, 10:254-266.
27. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., Antipin Y., Reva B., Goldberg A.P., Sander C., Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404.
28. Aparicio L.A., Abella V., Valladares M., Figueroa A. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition. Cell. Mol. Life Sci. 2013, 70:4463-4477.
29. Kim M.Y., Hur J., Jeong S. Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep. 2009, 42:125-130.
30. Wurth L. Versatility of RNA-binding proteins in cancer. Comp. Funct. Genom. 2012, 2012:178525.
31. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
32. Wang J., Guo Y., Chu H., Guan Y., Bi J., Wang B. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Int. J. Mol. Sci. 2013, 14:10015-10041.
33. Dassi E., Zuccotti P., Leo S., Provenzani A., Assfalg M., D'Onofrio M., Riva P., Quattrone A. Hyper conserved elements in vertebrate mRNA 3'-UTRs reveal a translational network of RNA-binding proteins controlled by HuR. Nucleic Acids Res. 2013, 41:3201-3216.
34. Lebedeva S., Jens M., Theil K., Schwanhausser B., Selbach M., Landthaler M., Rajewsky N. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 2011, 43:340-352.
35. Mukherjee N., Corcoran D.L., Nusbaum J.D., Reid D.W., Georgiev S., Hafner M., Ascano M., Tuschl T., Ohler U., Keene J.D. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 2011, 43:327-339.
36. Pullmann R., Kim H.H., Abdelmohsen K., Lal A., Martindale J.L., Yang X., Gorospe M. Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol. Cell. Biol. 2007, 27:6265-6278.
37. Bergalet J., Fawal M., Lopez C., Desjobert C., Lamant L., Delsol G., Morello D., Espinos E. HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas. Mol. Cancer Res. 2011, 9:485-496.
38. Kim H.H., Abdelmohsen K., Gorospe M. Regulation of HuR by DNA damage response kinases. J. Nucleic Acids 2010, 981487. (pii: 981487). 10.4061/2010/981487.
39. Srikantan S., Tominaga K., Gorospe M. Functional interplay between RNA-binding protein HuR and microRNAs. Curr. Protein Pept. Sci. 2012, 13:372-379.
40. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
41. Glorian V., Maillot G., Poles S., Iacovoni J.S., Favre G., Vagner S. HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ. 2011, 18:1692-1701.
42. Lal A., Kawai T., Yang X., Mazan-Mamczarz K., Gorospe M. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J. 2005, 24:1852-1862.
43. Mazan-Mamczarz K., Hagner P.R., Corl S., Srikantan S., Wood W.H., Becker K.G., Gorospe M., Keene J.D., Levenson A.S., Gartenhaus R.B. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene 2008, 27:6151-6163.
44. Fukao A., Sasano Y., Imataka H., Inoue K., Sakamoto H., Sonenberg N., Thoma C., Fujiwara T. The ELAV protein HuD stimulates cap-dependent translation in a Poly(A)- and eIF4A-dependent manner. Mol. Cell 2009, 36:1007-1017.
45. Leandersson K., Riesbeck K., Andersson T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res. 2006, 34:3988-3999.
46. Durie D., Lewis S.M., Liwak U., Kisilewicz M., Gorospe M., Holcik M. RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation. Oncogene 2011, 30:1460-1469.
47. Meng Z., King P.H., Nabors L.B., Jackson N.L., Chen C.Y., Emanuel P.D., Blume S.W. The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation. Nucleic Acids Res. 2005, 33:2962-2979.
48. Kullmann M., Gopfert U., Siewe B., Hengst L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev. 2002, 16:3087-3099.
49. Cuesta R., Martinez-Sanchez A., Gebauer F. miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells. Mol. Cell. Biol. 2009, 29:2841-2851.
50. Abdelmohsen K., Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA 2010, 1:214-229.
51. Topisirovic I., Siddiqui N., Borden K.L. The eukaryotic translation initiation factor 4E (eIF4E) and HuR RNA operons collaboratively regulate the expression of survival and proliferative genes. Cell Cycle 2009, 8:960-961.
52. Bell J.L., Wachter K., Muhleck B., Pazaitis N., Kohn M., Lederer M., Huttelmaier S. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?. Cell. Mol. Life Sci. 2013, 70:2657-2675.
53. Gutschner T., Hämmerle M., Pazaitis N., Bley N., Fiskin E., Uckelmann H., Heim A., Groβ M., Hofmann N., Geffers R., Skawran B., Longerich T., Breuhahn K., Schirmacher P., Mühleck B., Hüttelmaier S., Diederichs S. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma. Hepatology 2014, 59:1900-1911.
54. Huttelmaier S., Zenklusen D., Lederer M., Dictenberg J., Lorenz M., Meng X., Bassell G.J., Condeelis J., Singer R.H. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 2005, 438:512-515.
55. D'Ambrogio A., Nagaoka K., Richter J.D. Translational control of cell growth and malignancy by the CPEBs. Nat. Rev. Cancer 2013, 13:283-290.
56. Fernandez-Miranda G., Mendez R. The CPEB-family of proteins, translational control in senescence and cancer. Ageing Res. Rev. 2012, 11:460-472.
57. Ivshina M., Lasko P., Richter J.D. Cytoplasmic Polyadenylation Element Binding Proteins in Development, Health, and Disease. Annual review of cell and developmental biology 2014, 30:393-415.
58. Afroz T., Skrisovska L., Belloc E., Guillen-Boixet J., Mendez R., Allain F.H. A fly trap mechanism provides sequence-specific RNA recognition by CPEB proteins. Genes Dev. 2014, 28:1498-1514.
59. Villalba A., Coll O., Gebauer F. Cytoplasmic polyadenylation and translational control. Curr. Opin. Genet. Dev. 2011, 21:452-457.
60. Weill L., Belloc E., Bava F.A., Mendez R. Translational control by changes in poly(A) tail length: recycling mRNAs. Nat. Struct. Mol. Biol. 2012, 19:577-585.
61. Burns D.M., Richter J.D. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev. 2008, 22:3449-3460.
62. Burns D.M., D'Ambrogio A., Nottrott S., Richter J.D. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation. Nature 2011, 473:105-108.
63. D'Ambrogio A., Gu W., Udagawa T., Mello C.C., Richter J.D. Specific miRNA stabilization by Gld2-catalyzed monoadenylation. Cell Rep. 2012, 2:1537-1545.
64. Groisman I., Ivshina M., Marin V., Kennedy N.J., Davis R.J., Richter J.D. Control of cellular senescence by CPEB. Genes Dev. 2006, 20:2701-2712.
65. Nagaoka K., Udagawa T., Richter J.D. CPEB-mediated ZO-1 mRNA localization is required for epithelial tight-junction assembly and cell polarity. Nat. Commun. 2012, 3:675.
66. Nairismagi M.L., Vislovukh A., Meng Q., Kratassiouk G., Beldiman C., Petretich M., Groisman R., Fuchtbauer E.M., Harel-Bellan A., Groisman I. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene 2012, 31:4960-4966.
67. Alexandrov I.M., Ivshina M., Jung D.Y., Friedline R., Ko H.J., Xu M., O'Sullivan-Murphy B., Bortell R., Huang Y.T., Urano F., et al. Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance. PLoS Genet. 2012, 8:e1002457.
68. Ortiz-Zapater E., Pineda D., Martinez-Bosch N., Fernandez-Miranda G., Iglesias M., Alameda F., Moreno M., Eliscovich C., Eyras E., Real F.X., et al. Key contribution of CPEB4-mediated translational control to cancer progression. Nat. Med. 2012, 18:83-90.
69. Hagele S., Kuhn U., Boning M., Katschinski D.M. Cytoplasmic polyadenylation-element-binding protein (CPEB)1 and 2 bind to the HIF-1alpha mRNA 3'-UTR and modulate HIF-1alpha protein expression. Biochem. J. 2009, 417:235-246.
70. Chen P.J., Huang Y.S. CPEB2-eEF2 interaction impedes HIF-1alpha RNA translation. EMBO J. 2012, 31:959-971.
71. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
72. Spriggs K.A., Stoneley M., Bushell M., Willis A.E. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell. 2008, 100:27-38.
73. Shatsky I.N., Dmitriev S.E., Andreev D.E., Terenin I.M. Transcriptome-wide studies uncover the diversity of modes of mRNA recruitment to eukaryotic ribosomes. Crit. Rev. Biochem. Mol. Biol. 2014, 49:164-177.
74. Komar A.A., Hatzoglou M. Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle 2011, 10:229-240.
75. Yanagiya A., Suyama E., Adachi H., Svitkin Y.V., Aza-Blanc P., Imataka H., Mikami S., Martineau Y., Ronai Z.A., Sonenberg N. Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol. Cell 2012, 46:847-858.
76. Braunstein S., Karpisheva K., Pola C., Goldberg J., Hochman T., Yee H., Cangiarella J., Arju R., Formenti S.C., Schneider R.J. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol. Cell 2007, 28:501-512.
77. Morfoisse F., Kuchnio A., Frainay C., Gomez-Brouchet A., Delisle M.B., Marzi S., Helfer A.C., Hantelys F., Pujol F., Guillermet-Guibert J., et al. Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1alpha-independent translation-mediated mechanism. Cell Rep. 2014, 6:155-167.
78. Evdokimova V., Tognon C., Ng T., Ruzanov P., Melnyk N., Fink D., Sorokin A., Ovchinnikov L.P., Davicioni E., Triche T.J., et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009, 15:402-415.
79. King H.A., Cobbold L.C., Willis A.E. The role of IRES trans-acting factors in regulating translation initiation. Biochem. Soc. Trans. 2010, 38:1581-1586.
80. Martinez-Salas E., Lozano G., Fernandez-Chamorro J., Francisco-Velilla R., Galan A., Diaz R. RNA-binding proteins impacting on internal initiation of translation. Int. J. Mol. Sci. 2013, 14:21705-21726.
81. Brenet F., Socci N.D., Sonenberg N., Holland E.C. Akt phosphorylation of La regulates specific mRNA translation in glial progenitors. Oncogene 2009, 28:128-139.
82. Rutjes S.A., Utz P.J., van der Heijden A., Broekhuis C., van Venrooij W.J., Pruijn G.J. The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ. 1999, 6:976-986.
83. Wolin S.L., Cedervall T. The La protein. Annu. Rev. Biochem. 2002, 71:375-403.
84. Holcik M., Korneluk R.G. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol. Cell. Biol. 2000, 20:4648-4657.
85. Trotta R., Vignudelli T., Candini O., Intine R.V., Pecorari L., Guerzoni C., Santilli G., Byrom M.W., Goldoni S., Ford L.P., et al. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell 2003, 3:145-160.
86. Gu L., Zhu N., Zhang H., Durden D.L., Feng Y., Zhou M. Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 2009, 15:363-375.
87. Petz M., Them N., Huber H., Beug H., Mikulits W. La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition. Nucleic Acids Res. 2012, 40:9738-9749.
88. Sommer G., Rossa C., Chi A.C., Neville B.W., Heise T. Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. PLoS One 2011, 6:e25402.
89. Romanelli M.G., Diani E., Lievens P.M. New insights into functional roles of the polypyrimidine tract-binding protein. Int. J. Mol. Sci. 2013, 14:22906-22932.
90. Hussey G.S., Chaudhury A., Dawson A.E., Lindner D.J., Knudsen C.R., Wilce M.C., Merrick W.C., Howe P.H. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol. Cell 2011, 41:419-431.
91. Biyanee A., Ohnheiser J., Singh P., Klempnauer K.H. A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation. Oncogene 2014, 10.1038/onc.2014.83.
92. Eswarappa S.M., Potdar A.A., Koch W.J., Fan Y., Vasu K., Lindner D., Willard B., Graham L.M., DiCorleto P.E., Fox P.L. Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell 2014, 157:1605-1618.
93. Castello A., Horos R., Strein C., Fischer B., Eichelbaum K., Steinmetz L.M., Krijgsveld J., Hentze M.W. System-wide identification of RNA-binding proteins by interactome capture. Nat. Protoc. 2013, 8:491-500.
94. Ingolia N.T., Brar G.A., Rouskin S., McGeachy A.M., Weissman J.S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 2012, 7:1534-1550.
95. Konig J., Zarnack K., Rot G., Curk T., Kayikci M., Zupan B., Turner D.J., Luscombe N.M., Ule J. iCLIP-transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. J. Vis. Exp. 2011, 10.1371/journal.pgen.1002977.
96. Mendez R., Murthy K.G., Ryan K., Manley J.L., Richter J.D. Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex. Mol. Cell 2000, 6:1253-1259.
97. Tiedje C., Ronkina N., Tehrani M., Dhamija S., Laass K., Holtmann H., Kotlyarov A., Gaestel M. The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet. 2012, 8:e1002977.